Folate Therapy and In-Stent Restenosis after Coronary Stenting
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B6, and vitamin B12 (referred to as folate therapy) on the risk of angiographic restenosis after coronary-stent placement in a double-blind, multicenter trial. METHODS: A total of 636 patients who had undergone successful coronary stenting were randomly assigned to receive 1 mg of folic acid, 5 mg of vitamin B6, and 1 mg of vitamin B12 intravenously, followed by daily oral doses of 1.2 mg of folic acid, 48 mg of vitamin B6, and 60 microg of vitamin B12 for six months, or to receive placebo. The angiographic end points (minimal luminal diameter, late loss, and restenosis rate) were assessed at six months by means of quantitative coronary angiography. RESULTS: At follow-up, the mean (+/-SD) minimal luminal diameter was significantly smaller in the folate group than in the placebo group (1.59+/-0.62 mm vs. 1.74+/-0.64 mm, P=0.008), and the extent of late luminal loss was greater (0.90+/-0.55 mm vs. 0.76+/-0.58 mm, P=0.004). The restenosis rate was higher in the folate group than in the placebo group (34.5 percent vs. 26.5 percent, P=0.05), and a higher percentage of patients in the folate group required repeated target-vessel revascularization (15.8 percent vs. 10.6 percent, P=0.05). Folate therapy had adverse effects on the risk of restenosis in all subgroups except for women, patients with diabetes, and patients with markedly elevated homocysteine levels (15 micromol per liter or more) at baseline. CONCLUSIONS: Contrary to previous findings, the administration of folate, vitamin B6, and vitamin B12 after coronary stenting may increase the risk of in-stent restenosis and the need for target-vessel revascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Trials of homocysteine-reducing vitamin therapy have been disappointing, however.78 -82”
From Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee (2006) · cites this paper as [81]
Citations
Cites
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Patterns and Mechanisms of In-Stent Restenosis: A Serial Intravascular Ultrasound Study
Hoffmann, R., Mintz, G. S., Dussaillant, G. R., Popma, J. J., Pichard, A. D., Satler, L. F., Kent, K. M., Griffin, J., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1247 · Cited by 1,247
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. F., & Rosenberg, I. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401901 · Cited by 1,117
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J., & James, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002725200 · Cited by 640
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Self-citationIngrosso, D., Cimmino, A., Perna, A. F., Masella, L., De Santo, N. G., De Bonis, M. L., Vacca, M., D'Esposito, M., D'Urso, M., Galletti, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13372-7 · Cited by 427
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Research works printed but not linked: 3
- Cook J, 2002, J Vasc Surg, 35, 158
- 10.1097/00043798-200102000-00002 · doi:10.1097/00043798-200102000-00002
- Benoit C, 1999, Arch Mal Coeur Vaiss, 92, 1457
Cited by
Items 201–300 of 334
Homocysteine and cardiovascular disease: should we treat?
Potter, K. (2008) · PubMed · Cited by 11
Liu, F., Zhang, J., Yu, S., Wang, R., Wang, B., Lai, L., Yin, H., & Liu, G. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.138 · Cited by 7
Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link?
Rossi, G. P., Seccia, T. M., & Pessina, A. C. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.353 · Cited by 7
Abularrage, C. J., Sidawy, A. N., White, P. W., Aidinian, G., DeZee, K. J., Weiswasser, J. M., & Arora, S. (2007) · Vascular and Endovascular Surgery · doi:10.1177/1538574407301692 · Cited by 7
Aortic thrombus and pulmonary embolism in a patient with hyperhomocysteinemia
Goette, A., Hammwöhner, M., Dierkes, J., Lachmuth, J., Frölich, J. C., Klein, H., & Bode‐Böger, S. M. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0601 · Cited by 7
Elevated plasma homocysteine: cause or consequence of myocardial infarction?
Hultdin, J., Thøgersen, A. M., Jansson, J.-H., Nilsson, T., Weinehall, L., & Hallmans, G. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01415.x · Cited by 7
Olthof, M. R., Bots, M. L., Katan, M., & Verhoef, P. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010004 · Cited by 8
Homocysteine, traditional risk factors and impaired renal function in coronary artery disease
Pizzolo, F., Friso, S., Olivieri, O., Martinelli, N., Bozzini, C., Guarini, P., Trabetti, E., Faccini, G., Corrocher, R., & Girelli, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01714.x · Cited by 8
Micronutrient supplements: Who needs them? A personal view
Shenkin, A. (2013) · Nutrition Bulletin · doi:10.1111/nbu.12022 · Cited by 8
Acute Myocardial Infarction in a Young Man with Hyperhomocysteinemia and Pulmonary Tuberculosis
Ren, M., Zhang, C., Zhang, X., & Zhong, J. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4565 · Cited by 8
Verdoia, M., Schaffer, A., Barbieri, L., Cassetti, E., Giovine, G. D., Marino, P. N., & Luca, G. D. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32836574f0 · Cited by 6
Zeng, R., Li, J., Liao, P., & Zhang, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.131 · Cited by 6
Homocysteine and Stroke Prevention: Have the Trials Settled the Issue?
Spence, J. D. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00057.x · Cited by 7
Laxdal, E. H., Wirsching, J., Pedersen, G., Bertz, A., Amundsen, S. R., Dregelid, E. B., Jonung, T., Nyheim, T., & Aune, S. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.06.032 · Cited by 6
Is Homocysteine a Risk Factor for Atherothrombotic Cardiovascular Disease?
Akhtar, N. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.014 · Cited by 6
Ye, M., Chen, X., Mao, S., Zhou, J., Liu, M., & Wu, Y. H. (2022) · Pteridines · doi:10.1515/pteridines-2022-0041 · Cited by 5
Pietruszyńska-Reszetarska, A., Pietruszyński, R., Majsterek, I., Popławski, T., Skrzypek, M., Kolesińska, B., Waśko, J., Watała, C. W., Kapusta, J., & Irzmański, R. (2024) · Reports — Medical Cases Images and Videos · doi:10.3390/reports7010006 · Cited by 5
Drugs for Cardiovascular Disease Prevention in Women
WENGER, N. K. (2008) · Drugs · doi:10.2165/00003495-200868030-00006 · Cited by 7
Polymorphism in Methylentetrahydrofolate Reductase Gene: Important Role in Diseases
Kiseljaković, E., Jadrić, R., Hasić, S., Skenderi, F., Resić, H., & Winterhalter-Jadrić, M. (2008) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2008.2975 · Cited by 7
Nutrients, Phytomedicines, and Mind-Body Treatments for Substance Abuse
Brown, R. P., & Gerbarg, P. L. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_109 · Cited by 6
Approaching the End of the Homocysteine Hype?
Sunder–Plassmann, G., Winkelmayer, W. C., & Födinger, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.007 · Cited by 6
Antioxidant Treatment and Prevention of Human Sperm DNA Fragmentation: Role in Health and Fertility
Abad, C., Frau, J. G., Hannaoui, N., & García-Peiró, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800872-0.00035-4 · Cited by 5
Optimal care of lupus nephritis patients
Jadoul, M. Y. (2005) · Lupus · doi:10.1191/0961203305lu2063oa · Cited by 5
Tran, M. T., & Spencer, F. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.10.018 · Cited by 5
Folic acid supplementation: too much of a good thing?
Hauser, W. A. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.169516 · Cited by 5
Primary Prevention of Ischemic Heart Disease
Meadows, J. L., Danik, J. S., & Albert, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50015-2 · Cited by 4
Acute myocardial infarction in a young patient with hyperhomocysteinaemia
Ukachukwu, V., Idris, S., & McIlwee, A. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-007489 · Cited by 4
Ronco, A. M., Llanos, M. N., Tamayo, D., & Hirsch, S. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.12.005 · Cited by 4
Cardiovascular Risk Factors in the Elderly
Zieman, S. J., & Malasky, B. R. (2005) · Humana Press eBooks · doi:10.1385/1-59259-941-9:079 · Cited by 4
Total Homocysteine Concentration and Associated Cardiovascular and Renal Implications in Adults
Bergen, C., & Compher, C. W. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200601000-00009 · Cited by 6
Toth, P. P., Shammas, N. W., Dippel, E. J., & Foreman, B. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10027-2 · Cited by 5
Mandatory fortification of flour with folic acid: an overdue public health opportunity
Stanley, F. J., & MABERLY, G. F. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00195.x · Cited by 4
Guelpen, B. R. V. (2006) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 5
Guéant, J., Elia, M., & Romano, A. G. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.068 · Cited by 4
Folate Therapy and In-Stent Restenosis
Stanger, O., Fowler, B., & Herrmann, W. (2004) · New England Journal of Medicine · doi:10.1056/nejm200409163511220 · Cited by 4
Hasbun, P. G., Martinez, E. C., Pascucci, J. A., Castillo, J. L., Alonso-Ramírez, A. C., de Marza, M. M. G., Illán, J., Zuñiga, B. S. S., Davila, K. F. C., Monar, G. V. F., et al. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01178-z · Cited by 9
Methyl donor diet attenuates intimal hyperplasia after vascular injury in rats
Jiang, Q.-L., Li, T., Xu, Q., Zeng, Y., Wang, W., Zhang, B., Yao, Q., Jiang, J., & Jiang, J. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109486 · Cited by 3
Antioxidant and B-vitamins and Atherosclerosis
Hwang-Levine, J., Mack, W. J., & Hodis, H. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-542-2_12 · Cited by 3
Hyperhomocysteinemia and diabetic macroangiopathy: guilty or innocent bystander?
Buysschaert, M., Preumont, V., & Hermans, M. P. (2007) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2006.11.013 · Cited by 3
Willems, H. P. J., den Heijer, M., Gerrits, W. B. J., Schurgers, L. J., HAVEKES, M. L., Blom, H. J., & Bos, G. M. J. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.10.009 · Cited by 4
Preusch, M. R., Bea, F., Yang, S. H.-Y., Kreuzer, J., Isermann, B., Pedal, I., Rosenfeld, M. E., Katus, H. A., & Blessing, E. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318070c66a · Cited by 3
Are we losing homocysteine as a cardiovascular risk factor?
Bunout, D. C., & Hirsch, S. (2005) · Nutrition · doi:10.1016/j.nut.2005.04.007 · Cited by 3
Foliumzuur draagt niet bij aan de preventie van hart- en vaatziekten
Wiersma, T. (2006) · Huisarts en Wetenschap · doi:10.1007/bf03084838 · Cited by 3
NHG-Standaard Cardiovasculair risicomanagement
Boukes, F., Geijer, R. M. M., Opstelten, W., Wiersma, T., & Goudswaard, A. N. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_20 · Cited by 3
Homocysteine and Cardiovascular Disease
Das, J. R., & Kaul, S. (2008) · Wiley eBooks · doi:10.1002/9780470475973.ch17 · Cited by 4
Devendra, G. P., & Krasuski, R. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833e4f13 · Cited by 3
The drug-based pipeline against restenosis
Keller, P., Ibrahim, R., & Tardif, J. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.1.67 · Cited by 3
Homocysteine and Cardiovascular Disease
KHAN, M. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012406061-6/50070-9 · Cited by 3
Meng, H., So, H., Yan, X., Jin, Y., Lam, S. H. M., Kwok, T., & Tam, L. (2026) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x261423837 · Cited by 3
Marcucci, R., Brunelli, T., Fedi, S., Pepe, G., Giusti, B., Gori, A. M., Prisco, D., Falai, M., Margheri, M., Abbate, R., et al. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01439.x · Cited by 4
Stroke as a Complication of General Medical Disorders
George, P. M., & Albers, G. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00011-4 · Cited by 2
Nardin, M., Verdoia, M., Gioscia, R., Negro, F., & Luca, G. D. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.004 · Cited by 2
Management of Type 2 Diabetes Mellitus
Dungan, K. M., & Buse, J. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00048-4 · Cited by 3
Homocysteine research – where do we stand and where are we going?
Herrmann, W. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.171 · Cited by 2
Should we routinely supplement coronary patients with folate therapy to prevent in-stent restenosis?
Halabi, A. R., & Harrington, R. A. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.014 · Cited by 2
Leefstijlinterventie ter preventie van hart- en vaatziekten
Fokkema, M. R., Muskiet, F. A. J., & van Doormaal, J. J. (2005) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Zhou, R., Zhu, Z., Wang, Z., Dong, M., Huang, L., Wang, S., Zhang, X., & Liu, F. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1644302 · Cited by 2
Making the Connection Between Diet and Nutrition and Cardiovascular and Alzheimer’s Diseases
McDonald, P. (2008) · EXPLORE · doi:10.1016/j.explore.2007.12.006 · Cited by 1
Garcia, S. A., Murray, S. T. N., MORITZ, T. E., Pierpont, G. L., Goldman, S., Larsen, G. C., Littooy, F. N., Ward, H. B., & McFalls, E. O. (2010) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2010.03.006 · Cited by 1
Is homocysteine a relevant cardiovascular risk factor?
Das, J. R., & Kaul, S. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0026-z · Cited by 1
Hyperhomocystéinémie : un vrai facteur de risque cardiovasculaire ?
Sène, D., & Cacoub, P. (2013) · EMC - Cardiologie · doi:10.1016/s1166-4568(12)45112-9 · Cited by 1
Cholesterol embolisation syndrome
Nair, K., Krishnan, H. S., & Tharakan, J. M. (2005) · Heart · doi:10.1136/hrt.2004.051458 · Cited by 1
Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
Tabrizchi, R. (2004) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2.6.935 · Cited by 1
Stroke as a Complication of General Medical Disorders
Delio, P. R., & Albers, G. W. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50064-x · Cited by 1
Mengel, K. (2012) · Springer eBooks · doi:10.1007/978-3-642-29242-2_8 · Cited by 1
Mengel, K. (2011) · Springer eBooks · doi:10.1007/978-3-642-21992-4_8 · Cited by 1
李, 超. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111482 · Cited by 1
Controversias sobre el uso de micronutrientes
Giraldo, H. J. U., Betancur, M. A. Q., García, L. A. R., Merchán, C. A. G., & Grisales, J. C. B. (2009) · Revista Médica de Risaralda · doi:10.22517/25395203.745 · Cited by 1
Complementary and Alternative Medicine in Cardiovascular Care
Islam, A., Rahman, M., Ahmed, M. U., Chowdhury, M., Khair, A., Ullah, M., & Yeasmin, L. (1970) · Cardiovascular Journal · doi:10.3329/cardio.v1i1.8211 · Cited by 1
Vizcaíno, G., & Vizcaíno, J. (2017) · Investigación Clínica · Cited by 7
Effect of Folic Acid Supplementation in Postmenopausal Women
Paradisi, G., Ianniello, F., Basile, F., Cesare, C. D., Quagliozzi, L., Donati, L., & Caruso, A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-373-2_17 · Cited by 1
[Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi, H., Young, P., Díaz, M. L., Schropp, J., Forrester, M., & Freixas, E. (2005) · PubMed · Cited by 1
Homocysteine as an Emerging Risk Factor for Cardiovascular Disease in the Elderly
Giusti, B., Gori, A. M., Marcucci, R., Saracini, C., Bolli, P., & Abbate, R. (2006) · Aging Health · doi:10.2217/1745509x.2.6.983 · Cited by 1
Pintó, X. (2006) · Medicina Clínica · doi:10.1157/13093736 · Cited by 1
Update in thrombosis: answers to perplexing questions.
Federman, D. G., Brescia, G., Moriarty, J. P., Haskell, S. G., Krishnamurthy, R., & Kirsner, R. S. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.10.907 · Cited by 1
McPherson, R., & Shepherd, J. (2006) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32801140ce · Cited by 1
Hernández, A. V. (2006) · RePub (Erasmus University Rotterdam) · Cited by 1
Pietruszyńska-Reszetarska, A., Pietruszyński, R., Majsterek, I., Popławski, T., Skrzypek, M., Kolesińska, B., Waśko, J., Watała, C. W., Kapusta, J., & Irzmański, R. (2023) · Preprints.org · doi:10.20944/preprints202307.0974.v1 · Cited by 1
Folsäure als Sekundärprophylaxe bei kardiovaskulären Erkrankungen
Kappert, K. (2007) · Der Kardiologe · doi:10.1007/s12181-007-0011-7
Past, present and future of ACE inhibitors
Molhoek, S. G. (2007) · Netherlands Heart Journal · doi:10.1007/bf03086052
KHAN, M. G. (2006) · Elsevier eBooks · doi:10.1016/b978-012406061-6/50085-0
Nutrition and Cardiovascular Disease: Homocysteine
Minno, M. N. D. D., Tremoli, E., & Minno, G. D. (2011) · Wiley eBooks · doi:10.1002/9781444318456.ch49
Lipids, inflammation, and the Renin-Angiotensin System
van der Harst, P. (2006)
Current Controversies in Nutrition: Homocysteine Reduction and the B-Vitamin Controversy
Galland, L. (2012) · Alternative and Complementary Therapies · doi:10.1089/act.2012.18309
Sierpita, V. S., & Udani, J. K. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50036-1
Homocysteinemia, cardiovascular risk and long-term enteral nutrition
Zanetti, M., Barazzoni, R., & Guarnieri, G. (2007) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)
Hyperhomocystéinémie et macroangiopathie : « intox ou info » ?
Preumont, V., & Buysschaert, M. (2007) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(07)91998-7
von Eckardstein, A. (2005) · Journal of Laboratory Medicine · doi:10.1515/jlm.2005.023
Supplement Use in the Prevention and Treatment of Cardiovascular Disease in the Aging Population
Reilly, R. A., & Janson, C. H. (2012) · American Journal of Lifestyle Medicine · doi:10.1177/1559827612449595 · Cited by 1
Helpt folaattherapie stents open te houden?
Toll’s, P. J. M. M. (2005) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03058593
García, S., Murray, S. T. N., MORITZ, T. E., Pierpont, G. L., Goldman, S., Larsen, G. C., Littooy, F. N., Ward, H. B., & McFalls, E. O. (2010) · Annales de Chirurgie Vasculaire · doi:10.1016/j.acvfr.2010.12.025
Risk markers for a first myocardial infarction
Thøgersen, A. M. (2005) · DiVA at Umeå University (Umeå University)
Vascular risk factors and adipocyte dysfunction in metabolic syndrome
Hajer, G. R. (2008) · Utrecht University Repository (Utrecht University)
Clarifying the evidence: vitamin E, vitamin A, and folate.
Allan, G. M., & Payne, W. (2005) · Europe PMC (PubMed Central)
2007 Update Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women:
Taubert, K. A., Todd, B. A., Urbina, E. M., WENGER, N. K., Sherif, K., Smith, S. C., Sopko, G. S., Steinhorn, R. H., Neil, J. M., Öz, M. C., et al. (2007)
Sexual consequences of prostate cancer treatment.
Hoehn, J. B. (2005) · Europe PMC (PubMed Central)
Folate Therapy Harmful After Stenting
Herrmann, H. C. (2004) · Journal watch · doi:10.1056/jc200408130000001
Goes extension study Secondary prevention with folic acid: results of the
Liem, A. H., & Jukema, J. W. (2006)
The Role of Complementary Vitamins, Folate, Vitamin B6, and Vitamin B12, in Cardiovascular Disease
Mennen, L. I., Galan, P., & de Bree, A. (2005) · CRC Press eBooks · doi:10.1201/9781420038255-5
Metadata
- Authors
- Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E.
- Affiliations
- Klinikum Links der Weser (DE)
- Isala (NL)
- Diagram (Netherlands) (NL)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-24
- Volume
- 350
- Issue
- 26
- Pages
- 2673-2681
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1968517325
- Cited by
- 336
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 13 · 2013: 14 · 2012: 12
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- folate therapy, in-stent restenosis, coronary stenting, vitamin B6, vitamin B12, folic acid, homocysteine, late lumen loss, target vessel revascularization, coronary angioplasty, vitamin supplementation
- MeSH terms
- Aged, Coronary Disease, Coronary Vessels, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Homocysteine, Humans, Male, Middle Aged, Risk Factors, Vitamin B 12, Stents, Coronary Angiography, Treatment Failure, Hyperhomocysteinemia, Coronary Restenosis, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.